| Donna Gayle Porte, APRN-BC | |
|
2525 Broadway, Suite 200, Helena, MT 59604 | |
| (406) 457-4343 | |
| (406) 457-4344 |
| Full Name | Donna Gayle Porte |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 25 Years |
| Location | 2525 Broadway, Helena, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275634891 | NPI | - | NPPES |
| 4306372 | Medicaid | MT | |
| 370001 | Other | MT | BCBS OF MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | RN19923 (Montana) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | NUR-APRN-LIC-100271 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sentinel Healthcare Llc | 0244654135 | 2 |
News Archive
A large study of health records from 38 American children's hospitals has measured adverse events that most increase length of stay and overall cost. The researchers say their findings provide useful targets for hospital programs aimed at preventing harm to young patients.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired FORE Transcriptions USA Inc., along with its Indian operations, FORE Transcriptions Pvt. Ltd. With this acquisition, iMedX adds FORE's many clinics and solo practitioners in Southwestern Texas to its customer base and significantly enhances its global transcription production capacity in one of India's prime technology hubs.
Family doctors are advised to plan their response to managing a flu pandemic in this week's BMJ.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
A panel of experts says the government should by wary of suggestions that cutting payments to high cost areas and rewarding low-cost areas would help improve care and reduce Medicare costs.
› Verified 3 days ago
| Entity Name | Rchp Billings - Missoula Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376946913 PECOS PAC ID: 8426370842 Enrollment ID: O20150312000492 |
News Archive
A large study of health records from 38 American children's hospitals has measured adverse events that most increase length of stay and overall cost. The researchers say their findings provide useful targets for hospital programs aimed at preventing harm to young patients.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired FORE Transcriptions USA Inc., along with its Indian operations, FORE Transcriptions Pvt. Ltd. With this acquisition, iMedX adds FORE's many clinics and solo practitioners in Southwestern Texas to its customer base and significantly enhances its global transcription production capacity in one of India's prime technology hubs.
Family doctors are advised to plan their response to managing a flu pandemic in this week's BMJ.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
A panel of experts says the government should by wary of suggestions that cutting payments to high cost areas and rewarding low-cost areas would help improve care and reduce Medicare costs.
› Verified 3 days ago
| Entity Name | Sentinel Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710503099 PECOS PAC ID: 0244654135 Enrollment ID: O20200724001625 |
News Archive
A large study of health records from 38 American children's hospitals has measured adverse events that most increase length of stay and overall cost. The researchers say their findings provide useful targets for hospital programs aimed at preventing harm to young patients.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired FORE Transcriptions USA Inc., along with its Indian operations, FORE Transcriptions Pvt. Ltd. With this acquisition, iMedX adds FORE's many clinics and solo practitioners in Southwestern Texas to its customer base and significantly enhances its global transcription production capacity in one of India's prime technology hubs.
Family doctors are advised to plan their response to managing a flu pandemic in this week's BMJ.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
A panel of experts says the government should by wary of suggestions that cutting payments to high cost areas and rewarding low-cost areas would help improve care and reduce Medicare costs.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donna Gayle Porte, APRN-BC 10573 Horseback Ridge Rd, Missoula, MT 59804-5800 Ph: (406) 594-0955 | Donna Gayle Porte, APRN-BC 2525 Broadway, Suite 200, Helena, MT 59604 Ph: (406) 457-4343 |
News Archive
A large study of health records from 38 American children's hospitals has measured adverse events that most increase length of stay and overall cost. The researchers say their findings provide useful targets for hospital programs aimed at preventing harm to young patients.
iMedX Inc., a leading healthcare software and services company, announced today that it has acquired FORE Transcriptions USA Inc., along with its Indian operations, FORE Transcriptions Pvt. Ltd. With this acquisition, iMedX adds FORE's many clinics and solo practitioners in Southwestern Texas to its customer base and significantly enhances its global transcription production capacity in one of India's prime technology hubs.
Family doctors are advised to plan their response to managing a flu pandemic in this week's BMJ.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
A panel of experts says the government should by wary of suggestions that cutting payments to high cost areas and rewarding low-cost areas would help improve care and reduce Medicare costs.
› Verified 3 days ago